Aminalon (aminolone) capsules 0.25 №50

$8.00

Manufacturer: Ukraine

As part of the complex treatment of diseases of the central nervous system:

  • vascular diseases of the brain (atherosclerosis, lesions of cerebral vessels in arterial hypertension);
  • chronic cerebrovascular insufficiency with impaired memory, concentration, speech, dizziness, headache;
  • encephalopathy (alcoholic, post-stroke, post-traumatic);
  • cerebral palsy;
  • mental retardation in children (from 5 years old);
  • senile dementia (initial stages of dementia);
  • sea ​​and air sickness (for the prevention and treatment of motion sickness symptom complex).
Category:

Description

Ingredients

active substance: γ-aminobutyric acid;

1 capsule contains γ-aminobutyric acid in terms of 100% substance 250 mg;

excipients: methylcellulose, calcium stearate.

Dosage form

The capsules are hard.

Basic physical and chemical properties: hard gelatin capsules with a white body and a blue cap. The contents of the capsules are white powder or compressed mass.

Pharmacotherapeutic group

Other psychostimulants and nootropics. ATX code N06B X.

Pharmacodynamics

g-aminobutyric acid (GABA) is the main mediator of inhibitory processes in the central nervous system (CNS). The neurometabolic effect of the drug is due mainly to the stimulating effect on the GABAergic system, which ensures the normalization of the dynamics of nervous processes.

Under the influence of GABA, energy processes in brain tissues are also activated, their respiratory activity increases and blood supply improves.

The drug helps to restore motor activity, speech, and other cortical functions after a violation of cerebral circulation. It has a psychostimulating effect: it improves mental activity, memory, concentration of attention, and also weakens vestibular disorders, sleep disturbances.

Indications

As part of the complex treatment of diseases of the central nervous system:

  • vascular diseases of the brain (atherosclerosis, lesions of cerebral vessels in arterial hypertension);
  • chronic cerebrovascular insufficiency with impaired memory, concentration, speech, dizziness, headache;
  • encephalopathy (alcoholic, post-stroke, post-traumatic);
  • cerebral palsy;
  • mental retardation in children (from 5 years old);
  • senile dementia (initial stages of dementia);
  • sea ​​and air sickness (for the prevention and treatment of motion sickness symptom complex).

Contraindications

Hypersensitivity to any of the components of the drug; acute renal failure.

Directions

GABA capsules are taken orally before meals.

For adults, prescribe 2–5 capsules (500–1250 mg) per dose, depending on the course and severity of the disease. The daily dose is usually 6-12 capsules (1500-3000 mg) in 3 divided doses.

For children, Aminalon (GABA) capsules should be prescribed from the age of 5, depending on the course and severity of the disease, 2-12 capsules (500-3000 mg) per day. Distribute the daily dose into 3 doses, the course of treatment is from 2 weeks to 6 months. If necessary, conduct repeated courses (after consulting a doctor).

For the treatment of the symptom complex of motion sickness, adults are prescribed 2 capsules (500 mg) and children from 5 years old, 1 capsule (250 mg) 3 times a day for 3-4 days. As a preventive measure, adults should take 2 capsules (500 mg) 3 times a day for 3 days prior to a trip or possible motion sickness.

The duration of the course of treatment is determined by the doctor individually.